SCHEMBL7684154

SCHEMBL7684154

CC(=O)Nc1cc(C=O)ccc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
POLB P06746 2/20 0.54
HDAC1 Q13547 2/20 0.54
APOBEC3A P31941 1/20 0.54
GFER P55789 1/20 0.54
APOBEC3G Q9HC16 1/20 0.54
LMNA P02545 1/20 0.54
PHPT1 Q9NRX4 1/20 0.54
RAB9A P51151 2/20 0.52
PTGS2 P35354 1/20 0.52
MAPT P10636 2/20 0.49
NPC1 O15118 1/20 0.49
ALDH1A1 P00352 6/20 0.47
HPGD P15428 3/20 0.47
ALDH5A1 P51649 2/20 0.47
ABAT P80404 2/20 0.47
TRIM24 O15164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
TRIM33 Q9UPN9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29957610 1.00 KDM4E (0.54) KDM4ESMN1; SMN2POLBHDAC1APOBEC3A
SCHEMBL29953797 0.86 RAB9A (0.62) KDM4ESMN1; SMN2POLBHDAC1APOBEC3A
SCHEMBL29950977 0.82 ALDH1A1 (0.52) SMN1; SMN2POLBLMNARAB9AMAPT
SCHEMBL7215753 0.82 ALDH1A1 (0.52) SMN1; SMN2POLBLMNARAB9AMAPT
SCHEMBL30707812 0.81 ALDH1A1 (0.55) KDM4ESMN1; SMN2POLBLMNARAB9A
SCHEMBL9649413 0.81 ALDH1A1 (0.55) KDM4ESMN1; SMN2POLBLMNARAB9A
SCHEMBL13604782 0.80 KDM4E (0.60) KDM4ESMN1; SMN2POLBHDAC1APOBEC3A
SCHEMBL29953163 0.79 KDM4E (0.57) KDM4ESMN1; SMN2RAB9APTGS2ALDH1A1
SCHEMBL7013927 0.79 ALDH1A1 (0.52) KDM4ESMN1; SMN2POLBRAB9AMAPT
SCHEMBL6962491 0.78 POLB (0.47) KDM4ESMN1; SMN2POLBHDAC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190309289-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2019-10-10 US disclosed
US-10370654-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. (US) 2019-08-06 US disclosed
US-20180320170-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2018-11-08 US disclosed
US-9944925-B2 Processes and host cells for genome, pathway, and biomolecular engineering ENEVOLV, INC. 2018-04-17 US disclosed
US-20160186168-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. 2016-06-30 US disclosed
EP-3027754-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING enEvolv, Inc. (US) 2016-06-08 EP disclosed
WO-2015017866-A1 PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING ENEVOLV, INC. (US) 2015-02-05 WO disclosed
US-6492392-B1 INHIBITING TUMOR CELL PROLIFERATION KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-12-10 US disclosed
WO-2001085716-A1 2-PIPERIDONE COMPOUNDS FOR THE TREATMENT OF CANCER KYOWA HAKKO KOGYO CO., LTD (JP) 2001-11-15 WO disclosed
US-4117226-A INHIBITORS OF ANTIGEN-ANTIBODY REACTION SMITHKLINE CORPORATION (US) 1978-09-26 US disclosed